Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
- Home
- Products
- Transfected Stable Cell Lines
- Gene Knockdown Stable Cell Lines
- Gene Knockout Stable Cell Lines
- Gene Overexpression Stable Cell Lines
- Cas9 Stable Cell Lines
- GPCR Stable Cell Lines
- Immune Receptor Stable Cell Lines
- Ion Channel Stable Cell Lines
- Reporter Stable Cell Lines
- Ready-To-Assay Cells
- Coronavirus Receptor Stable Cell Lines
- Monkeypox Virus Related Cell Lines
- Biosimilar Stable Cell Lines
- Humanized Murine Tumor Cell Line
- ABC Transporter Stable Cell Lines
- DUB Stable Cell Lines
- E3 Ubiquitin Ligase Stable Cell Lines
- Nuclear Receptor Stable Cell Lines
- PDE Stable Cell Lines
- SLC Transporter Stable Cell Lines
- TLR Stable Cell Lines
- ADCC/ADCP Stable Cell Lines
- Immune Checkpoint Stable Cell Lines
- Chicken Ovalbumin (OVAL) Stable Cell Line
- Kinase Stable Cell Lines
- Gene Overexpression Stable Cell Lines-Others
- miRNA Overexpression Stable Cell Lines
- Cell Lysate
- Premade Virus Particles
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
- Virus-Like Particles (VLPs)
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
- Oligonucleotide Products
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
- RNA Interference Products
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
- Recombinant Drug Target Proteins
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
- Nanodiscs
- Immune & Cell Surface Receptors
- Cytokines & Growth Factors
- Cytokine Receptors
- Functional Proteins
- G Protein–Coupled Receptors (GPCRs)
- Immune Cell Surface Markers
- Immune Checkpoint Proteins
- Metabolic Enzymes
- Protein Modification Enzymes
- Regulatory & Disease-Related Target Proteins
- Transcription Factors
- Tumor-Associated Antigens
- Tyrosine Kinases
- Clones
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
- Kits
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
- BioSafety Testing Kits
- cDNA Synthesis Kits
- Residuals Detection Kit
- Cloning Kits
- Residual RNA Quantification Kits
- Cell Assay Kits
- Residual DNA Quantification Kits
- Direct PCR Kits
- Host Cell Protein Assay Kits
- NGS Library Preparation Kits
- Endotoxin Detection & Removal
- Gene Editing Kits
- LPS Extraction Kit
- miRNA cDNA Synthesis Kits
- Nucleic Acid Kits
- PCR Detection Kits
- Real Time PCR
- RT PCR Kits
- Transfection Reagents
- Virus Packaging Kits
- Protease/Phosphatase Assay Kits
- Virus Purification and Concentration Kits
- AAV Titer Detection Kits
- Anti-AAV Antibody ELISA Kits
- CB™ Sample Collection Kit
- mRNA Synthesis
- Antibody Conjugate Kit
- mRNA Delivery
- Enzymes
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
- Aptamers
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
- Adjuvants
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
- Laboratory Equipment
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
- Services
- Stable Cell Line Generation
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
- Target-based Drug Discovery Service
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
- Apoptosis Biochemical Screening and Profiling
- Epigenetic Screening & Profiling Services
- Acetyltransferase Screening and Profiling Service
- Bromodomain Screening and Profiling
- DNA Methyltransferase Screening and Profiling
- Histone Deacetylase Screening and Profiling Services
- Histone Demethylase Screening and Profiling Service
- Histone Methyltransferase Screening and Profiling
- PARP Screening and Profiling
- GPCR Screening & Profiling Services
- HSP90 Screening and Profiling
- Ion Channel Screening & Profiling Services
- Kinase Screening & Profiling Services
- Nuclear Receptor Screening & Profiling Services
- PDE Screening & Profiling Services
- Phosphatase Screening & Profiling Services
- Protease Screening & Profiling Services
- Transporter Screening & Profiling Services
- Ubiquitin Screening & Profiling Services
- DNA Damage Response (DDR) Target Screening & Profiling Services
- KRAS Screening & Functional Profiling Services
- Custom Viral Service
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
- AAV Service
- Virus-Like Particles (VLPs) Service
- Adenovirus Service
- Lentivirus Service
- Pseudovirus-Related Service
- Retrovirus Service
- GMP Grade Viral Service
- Herpes Simplex Virus (HSV) Service
- Measles Virus (MeV) Service
- Oncolytic Virus Service
- Rabies Virus (RABV) Service
- Replication-Competent Virus Testing
- Baculovirus Services
- Vaccinia Virus (VACV) Service
- Vesicular Stomatitis Virus (VSV) Service
- Custom Antibody Service
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
- Antibody-Drug Conjugation Service
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
- Protein Degrader Service
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
- Nucleotides Service
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
- Gene Synthesis and Cloning Service
- Gene Mutagenesis Service
- Custom Vector Construction and Modification Service
- Plasmid DNA Production Service
- Gene Expression Service
- Oligonucleotide Synthesis Service
- BNA Oligonucleotides Synthesis Service
- CpG Oligodeoxynucleotides Synthesis Service
- Oligo Pools
- sgRNA Library
- Single-Stranded DNA (ssDNA) Synthesis Service
- Custom mRNA Synthesis Service
- dsRNA Synthesis Service
- Modified DNA Oligo Synthesis Service
- Modified RNA Oligo Synthesis Service
- Circular Single-stranded DNA (ssDNA) Production Service
- Antisense Oligonucleotide Service
- Custom NGS Oligonucleotide Service
- Delivery System in Gene Therapy
- mcDNA Production Service
- Epigenomics Profiling Services
- Custom RNA Service
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
- Custom Libraries Construction Service
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
- cDNA Library Construction Service
- Full-Length cDNA Library Construction Service
- Normalized cDNA Library Construction Service
- SSH cDNA Library Construction Service
- Standard cDNA Library Construction Service
- Subtractive cDNA Library Construction Service
- Yeast Two-hybrid cDNA Library Construction Service
- Yeast One-hybrid cDNA Library Construction Service
- Yeast Three-hybrid cDNA Library Construction Service
- Mutant Library Construction Service
- Genomic Library Construction Service
- Shotgun Library Construction Service
- Fosmid Library Construction Service
- BAC Library Construction Service
- cDNA Library Construction Service
- Gene Editing Services
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
- Microbe Genome Editing Service
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
- Biosafety Testing Service
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
- Analytical Testing Service
- Characterization Service
- Material Testing Service
- Microbiology Services
- Virology Testing Service
- Microbial Cell Bank Release Testing Service
- Plasmid Release Testing Service
- Mammalian Cell Bank Release Testing Service
- Adventitious Virus Detection for Cell Bank Release
- Cell Line Authentication for Cell Bank Release
- Cell Viability Testing for Cell Bank Release
- Genetic Stability Testing for Cell Bank Release
- Species-Specific Virus Detection for Mammalian Cell Bank Release
- Tumorigenicity Testing Service for Mammalian Cell Bank Release
- Virus Seed Bank Release Testing Service
- Harvest Fluid and Unpurified Bulk Testing Service
- Drug Substance Release Testing Service
- DP Release and Stability Testing Service
- Liposome Formulation Specific Testing for Drug Product Release
- Lyophilized Formulation Specific Testing for Drug Product Release
- Nanoparticle Formulation Specific Testing for Drug Product Release
- Prefilled Syringe Specific Testing Service for Drug Product Release
- Stability Study Services for Drug Product Release
- Plant Genetic Modification Service
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
- Plant-based Protein Production Service
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
- Aptamer Discovery & SELEX Solutions
Aptamer Discovery & SELEX Solutions
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
- Applications
- Membrane Proteome Chip Antibody Off-Target Screening Service
Membrane Proteome Chip Antibody Off-Target Screening Service
Membrane Proteome Chip Antibody Off‑Target Screening
Native‑conformation | Quantitative | Cross‑reactivity free
- CGT Biosafety Testing
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
- Pandemic Detection Solutions
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
- CDMO
- HEK293 Cell-Based Production Platform
- cGMP Cell Line Development
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment. - GMP mRNA Production
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
- GMP Plasmid Production
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
- GMP Viral Vector Manufacturing
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
- AI
- AI-Driven Gene Editing and Therapy
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
- AI-Antibody Engineering Fusion
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
- AI-Driven Enzyme Engineering
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
- AI-Enhanced Small Molecule Screening
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
- AI-Driven Protein Degrader Drug Development
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
- Support
- About Us
Pages
Products
Figure 1. VEGF protein family. (Apte RS, et al., 2019)